Phase I Clinical Trial with HIV-1 gp160 Plasmid Vaccine in HIV-1-Infected Asymptomatic Subjects

2001 ◽  
Vol 20 (11) ◽  
pp. 800-803 ◽  
Author(s):  
R. Weber ◽  
W. Bossart ◽  
R. Cone ◽  
R. Luethy ◽  
K. Moelling
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Plasmid Vaccine ◽  
Asymptomatic Subjects ◽  
Hiv 1

scholarly journals Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

AIDS ◽  
2018 ◽  
Vol 32 (17) ◽  
pp. 2533-2545 ◽  
Author(s):  
Lorna Leal ◽  
Alberto C. Guardo ◽  
Sara Morón-López ◽  
Maria Salgado ◽  
Beatriz Mothe ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Therapeutic Vaccine ◽  
Phase I Clinical Trial ◽  
Hiv 1

First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants

AIDS ◽  
2008 ◽  
Vol 22 (1) ◽  
pp. 149-151 ◽  
Author(s):  
Julia L Hurwitz ◽  
Timothy D Lockey ◽  
Bart Jones ◽  
Pamela Freiden ◽  
Robert Sealy ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Envelope Protein ◽  
Phase I Clinical Trial ◽  
Protein Vaccine ◽  
Immune Activity ◽  
Gp140 Envelope ◽  
Study Participants ◽  
Hiv 1

scholarly journals Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein

AIDS Care ◽  
2011 ◽  
Vol 23 (8) ◽  
pp. 939-946 ◽  
Author(s):  
Anna Maria Luzi ◽  
Pietro Gallo ◽  
Anna Colucci ◽  
Simone Marcotullio ◽  
Stefania Bellino ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Tat Protein ◽  
Hiv 1 ◽  
Hiv Aids
Sign in / Sign up

Export Citation Format

Share Document